Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LQD vs GSK✓SelectedUSD · GSKLQD vs GSK performance historyLatest closeAs of-0.06%11/17
Stock and ETF performance explorer

LQD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+25.4%
GSK return
+104.0%
Excess return
-78.6%
Maximum drawdown
-25.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%-2.3%+2.3%+0.1%
7D-1.1%-3.0%+1.9%-0.9%
30D-0.3%+0.4%-0.6%-0.3%
3M-1.6%-1.2%-0.4%-1.6%
6M-2.4%+0.9%-3.4%-2.6%
YTD-3.0%+4.0%-7.0%-3.6%
1Y-2.4%+7.3%-9.7%-3.2%
3Y+12.7%+57.1%-44.4%+7.6%
5Y-4.7%+43.0%-47.7%-8.9%
10Y+25.4%+103.1%-77.7%+17.0%
All+25.4%+104.0%-78.6%+17.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling